Tyrosine kinase inhibitor discontinuation in patients with chronic myeloid leukemia: a single-institution experience

Overview of attention for article published in Journal of Hematology & Oncology, January 2019

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (91st percentile)
High Attention Score compared to outputs of the same age and source (84th percentile)

So far, Altmetric has seen 41 X posts from 33 X users, with an upper bound of 82,657 followers.

RT @GCC_Cortes: First large US experience with TKI discontinuation in CML published earlier this year. https://t.co/VRWRG2TQ0V

RT @GCC_Cortes: First large US experience with TKI discontinuation in CML published earlier this year. https://t.co/VRWRG2TQ0V

RT @docjunaid: Tyrosine kinase inhibitor discontinuation in patients with chronic myeloid leukemia: a single-institution experience | Journ…

RT @docjunaid: Tyrosine kinase inhibitor discontinuation in patients with chronic myeloid leukemia: a single-institution experience | Journ…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 37 additional X posts.